MA MSc PhD FHEA
Liz joined HERC in February 2018, from the Centre for the Advancement of Sustainable Medical Innovation (CASMI) - a policy research group in Oxford’s Radcliffe Department of Medicine. Her work focused on the health economics of cancer drugs, exploring the impact of technology appraisal processes on patient access to drugs, and the value that society places on treating cancer relative to other conditions.
Before joining CASMI, Liz worked as a freelance researcher with clients in pharmaceuticals and education, and as a product development manager in consumer healthcare.
Liz is working with Sarah Wordsworth and colleagues, initially on a series of Discrete Choice Experiments exploring clinician and public attitudes to antibiotics and antimicrobial resistance.
Improving the uptake and SusTainability of Effective interventions to promote Prudent antibiotic Use and Primary care (STEPUP): discrete choice experiments
MORRELL L., (2023)
Treatment Delays in Children and Young Adults with Lymphoma: report from an East Africa Lymphoma Cohort Study
Mawalla WF. et al, (2023), Blood Advances
We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment
MORRELL L. and charlton V., (2023), Health Economics, Policy and Law
Implementing antibiotic stewardship in high prescribing English general practices: a mixed-methods study
TONKIN-CRINE S. et al, (2023), British Journal of General Practice
Impact of the COVID-19 Pandemic on Community Antibiotic Prescribing and Stewardship: A Qualitative Interview Study with General Practitioners in England
Borek AJ. et al, (2021), Antibiotics, 10, 1531 - 1531